
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check the confirmation of hypertension by ambulatory monitoring, the CKD G3a A2 staging with the race-free eGFR and prior results for chronicity, losartan titration and the creatinine and potassium checks, empagliflozin without diabetes, the statin chosen at intermediate risk, the sick-day handling during gastroenteritis, and the APOL1 discussion. | ||
| provenance review | not_started | Sources: the Indiana Historical Society, 64 Parishes, the National Archives, the National Women's History Museum, the Gale Women in World History entry, the Lemelson Center, A'Lelia Bundles's site, and a passage of her biography quoted in Wikipedia. The NMAAHC pages, the New York Times obituary and the biography itself could not be read. | ||
| safe messaging review | not_started | No mental health claim is made; the mood screen is synthetic and below the threshold for a safety assessment. Her history is told with attention to slavery, poverty and the forms of address she refused, without stereotype; her work is treated as hers to direct. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-04-27 Progress note 05 (C-CDA) | Potassium, bicarbonate, creatinine and eGFR (CKD-EPI 2021, race-free) | Two to four weeks after starting or increasing losartan or empagliflozin; then every six months | Missed: the panel due two to four weeks after the losartan increase was not done because she was on a three-week tour with no laboratory day booked, and the panel planned a week after the gastroenteritis was missed for another trip. No harm judging by the sick-visit panel (potassium 4.9 mmol/L, creatinine 1.46 mg/dL while volume depleted) and today's results (potassium 4.7 mmol/L, bicarbonate 24 mmol/L, creatinine 1.31 mg/dL, eGFR 50). Corrective action: her office books each laboratory check on a home day before trips are scheduled (INT-012) |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-02-23 Progress note 02 (C-CDA) | Imaging | Echocardiogram | Ordered | Booked for the next visit |
| 2026-06-08 Progress note 06 (C-CDA) | Prevention | Breast cancer screening | Ordered | Mammogram every two years from 40; booked in two weeks on a day she is home |
| 2026-06-08 Progress note 06 (C-CDA) | Prevention | Colorectal cancer screening | Ordered | From 45; stool immunochemical test yearly, her choice so that she can mail it while traveling; colonoscopy discussed |
None.
None.
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-02-09 | Creatinine | 1.22 mg/dL (high) | High |
| 2026-02-09 | eGFR (CKD-EPI 2021, race-free) | 54 mL/min/1.73 m² (low) | Low |
| 2026-02-09 | Urine albumin-to-creatinine ratio | 286 mg/g (high) | High |
| 2026-02-09 | Total cholesterol | 250 mg/dL (high) | High |
| 2026-02-09 | LDL cholesterol | 174 mg/dL (high) | High |
| 2026-02-09 | HDL cholesterol | 46 mg/dL (low) | Low |
| 2026-02-09 | Triglycerides | 150 mg/dL (high) | High |
| 2026-02-23 | Urine albumin-to-creatinine ratio | 294 mg/g (high) | High |
| 2026-02-23 | Creatinine | 1.21 mg/dL (high) | High |
| 2026-02-23 | eGFR (CKD-EPI 2021, race-free) | 55 mL/min/1.73 m² (low) | Low |
| 2026-03-09 | Creatinine | 1.29 mg/dL (high) | High |
| 2026-03-09 | eGFR (CKD-EPI 2021, race-free) | 51 mL/min/1.73 m² (low) | Low |
| 2026-04-13 | Bicarbonate (total CO2) | 21 mmol/L (low) | Low |
| 2026-04-13 | Creatinine | 1.46 mg/dL (high) | High |
| 2026-04-13 | eGFR (CKD-EPI 2021, race-free) | 44 mL/min/1.73 m² (low) | Low |
| 2026-04-27 | Creatinine | 1.31 mg/dL (high) | High |
| 2026-04-27 | eGFR (CKD-EPI 2021, race-free) | 50 mL/min/1.73 m² (low) | Low |
| 2026-04-27 | Urine albumin-to-creatinine ratio | 176 mg/g (high) | High |
| 2026-04-27 | HDL cholesterol | 48 mg/dL (low) | Low |
| 2026-08-17 | Creatinine | 1.3 mg/dL (high) | High |
| 2026-08-17 | eGFR (CKD-EPI 2021, race-free) | 50 mL/min/1.73 m² (low) | Low |
| 2026-08-17 | Urine albumin-to-creatinine ratio | 128 mg/g (high) | High |